L
Liisa Sailas
Researcher at Turku University Hospital
Publications - 9
Citations - 566
Liisa Sailas is an academic researcher from Turku University Hospital. The author has contributed to research in topics: Breast cancer & Health care. The author has an hindex of 7, co-authored 7 publications receiving 497 citations.
Papers
More filters
Journal ArticleDOI
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
Harri Sihto,Harri Sihto,Johan Lundin,Johan Lundin,Mikael Lundin,Tiina Lehtimäki,Ari Ristimäki,Ari Ristimäki,Kaija Holli,Liisa Sailas,Vesa Kataja,Taina Turpeenniemi-Hujanen,Jorma Isola,Päivi Heikkilä,Heikki Joensuu,Heikki Joensuu +15 more
TL;DR: Breast tumor biological subtypes have a tendency to give rise to first distant metastases at certain body sites, and several primary tumor proteins were associated with homing of breast cancer cells.
Journal ArticleDOI
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
Heikki Joensuu,Judith Fraser,Hans Wildiers,Riikka Huovinen,Päivi Auvinen,Meri Utriainen,Paul Nyandoto,Kenneth Villman,P. Halonen,Helena Granstam-Bjorneklett,Lotta Lundgren,Liisa Sailas,Taina Turpeenniemi-Hujanen,Minna Tanner,Jeffrey Yachnin,Diana Ritchie,Oskar Johansson,Teppo Huttunen,Patrick Neven,Peter Canney,Vernon Harvey,Pirkko-Liisa Kellokumpu-Lehtinen,Henrik Lindman +22 more
TL;DR: Nine weeks of trastuzumab was not noninferior to 1 year of trastsimab when given with similar chemotherapy, andCardiac safety was better in the 9-week group, while the docetaxel dosing with trastizumab requires further study.
Journal ArticleDOI
Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening
Harri Sihto,Johan Lundin,Tiina Lehtimäki,Maarit Sarlomo-Rikala,Ralf Bützow,Kaija Holli,Liisa Sailas,V. Kataja,Mikael Lundin,Taina Turpeenniemi-Hujanen,Jorma Isola,Päivi Heikkilä,Heikki Joensuu +12 more
TL;DR: Molecular subtype distribution of screen-detected breast cancer differs from that of cancers found outside of screening and accounts in part for the better outcome ofScreen-detection cancer.
Journal ArticleDOI
Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer
Juho Konsti,Mikael Lundin,Heikki Joensuu,Heikki Joensuu,Tiina Lehtimäki,Harri Sihto,Kaija Holli,Taina Turpeenniemi-Hujanen,Vesa Kataja,Liisa Sailas,Jorma Isola,Johan Lundin,Johan Lundin +12 more
TL;DR: Running high-throughput automated IHC algorithms on a virtual microscopy platform is feasible and in multivariate survival analysis, the automated assessment of Ki-67 extent of staining is a significant and independent predictor of outcome in breast cancer.
Journal ArticleDOI
Hypofractionated stereotactic body radiotherapy for localized prostate cancer – first Nordic clinical experience
Kristiina Koskela,Jan-Erik Palmgren,Janne Heikkilä,Heli Virsunen,Liisa Sailas,Päivi Auvinen,Jan Seppälä,Vesa Kataja +7 more
TL;DR: The toxicity of robotic SBRT in a large clinical cohort of PCa patients was tolerable and the early PSA response was good in all risk groups, including also high-risk patients (D’Amico risk stratification).